Mary Clare Rea

Title: The Innovative Contributions of Mary Clare Rea

Introduction

Mary Clare Rea is a notable inventor based in Fermoy, Ireland. She has made significant strides in the field of microbiology, particularly with her work on bacteriocins. Her innovative approach has led to the development of a novel anti-microbial agent that showcases her expertise and dedication to scientific advancement.

Latest Patents

Mary Clare Rea holds 1 patent for her invention related to bacteriocins. The patent describes a novel bacteriocin with nisin-like properties, designated as lacticin 3147. This bacteriocin has a molecular weight of approximately 2.8 kDa and exhibits inhibiting activity against various bacteria, including lactococci, lactobacilli, enterococci, bacilli, leuconostocs, pediococci, clostridia, staphylococci, and streptococci. It is sensitive to proteases such as trypsin, alpha-chymotrypsin, proteinase K, and pronase E, but not to pepsin. Additionally, it demonstrates heat stability, activity at acid pH, and the capability of inhibiting nisin-producing bacterial strains.

Career Highlights

Mary Clare Rea is associated with Teagasc, where she continues to contribute to research and innovation in her field. Her work has garnered attention for its potential applications in food safety and preservation, showcasing her commitment to improving public health through scientific research.

Collaborations

Mary Clare Rea has collaborated with notable colleagues, including Reynolds Paul Ross and Marie Philippa Ryan. These partnerships have further enriched her research and expanded the impact of her inventions.

Conclusion

Mary Clare Rea's contributions to the field of microbiology through her innovative work on bacteriocins highlight her role as a leading inventor. Her dedication to scientific research continues to pave the way for advancements in anti-microbial agents.